Beth earned a B.S. in Business Administration in Marketing from Miami University. About Macular Telangiectasia Type 2 (MacTel) Macular Telangiectasia Type 2 (MacTel), or idiopathic macular ...

In this role, Beth will lead the commercial organization, including preparing for the U.S. launch of ENCELTO TM (revakinagene taroretcel-lwey), the first and only approved treatment for adults with ...